DESONIDE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 162 adverse event reports in the FDA FAERS database where DESONIDE was used for Psoriasis.
Most Reported Side Effects for DESONIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 931 | 69.4% | 5 | 208 |
| Macular degeneration | 752 | 56.0% | 0 | 211 |
| Off label use | 230 | 17.1% | 3 | 196 |
| Therapeutic product effect incomplete | 226 | 16.8% | 0 | 195 |
| Pain | 217 | 16.2% | 0 | 187 |
| Erythema | 212 | 15.8% | 0 | 145 |
| Chronic sinusitis | 203 | 15.1% | 0 | 200 |
| Pyrexia | 199 | 14.8% | 0 | 194 |
| Malaise | 196 | 14.6% | 0 | 192 |
| Nausea | 193 | 14.4% | 0 | 186 |
| Weight decreased | 193 | 14.4% | 0 | 186 |
| Paraesthesia oral | 189 | 14.1% | 0 | 186 |
| Infusion related reaction | 176 | 13.1% | 0 | 173 |
| Dyspepsia | 169 | 12.6% | 0 | 166 |
| Procedural pain | 168 | 12.5% | 0 | 165 |
Other Indications for DESONIDE
Product used for unknown indication (772)
Eczema (52)
Dermatitis atopic (35)
Rash (24)
Dermatitis (15)
Pruritus (12)
Rosacea (12)
Seborrhoeic dermatitis (11)
Skin disorder (11)
Dry skin (10)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)